FDA notifications. Generic efavirenz/emtricitabine/fenofovir has tentative approval.
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000480:Alkynes; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D048588:Benzoxazines / Q000008:administration & dosage; D003521:Cyclopropanes; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004338:Drug Combinations; D016568:Drugs, Generic; D000068679:Emtricitabine; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D063065:Organophosphonates / Q000008:administration & dosage*; D000068698:Tenofovir; D014481:United States; D014486:United States Food and Drug Administration
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D004338:Drug Combinations; D016568:Drugs, Generic; D063065:Organophosphonates; D003841:Deoxycytidine; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine; C098320:efavirenz